Both in Biotechnology
Tectonic Therapeutic vs Surrozen
Over the past year TECX returned +21.3% and SRZN returned +151.4%; their daily moves had a correlation of 0.16.
TECX +21.3% SRZN +151.4%Growth of $1, one year, split-adjusted
| Metric | TECX | SRZN |
|---|---|---|
| Price | $20.30 | $31.65 |
| Market cap | $396.9M | $372.0M |
| Today | +6.95% | +5.08% |
| 1 month | −9.4% | +20.0% |
| 6 months | −30.0% | −7.3% |
| Year to date | −2.7% | +40.0% |
| 1 year | +15.9% | +142.3% |
| Revenue growth (YoY) | — | +408.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 32.3× |
| Net cash | $226.9M | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 171.0% |
| Short % of float | 19.1% | 37.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).